•  
  •  
  •  
  •  

2026-05-22 22:59:31

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport

Keywords Selected:  SemaglutideInjection

Stock Report

  • OneSource Supports Second Generic Semaglutide Approval in Canada
  • OneSource's Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner
  • Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price Starting from MRP INR 1,290
  • Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
  • Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry

Latest Post

  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025